Literature DB >> 8755564

A novel strategy for generating monoclonal antibodies from single, isolated lymphocytes producing antibodies of defined specificities.

J S Babcook1, K B Leslie, O A Olsen, R A Salmon, J W Schrader.   

Abstract

We report a novel approach to the generation of monoclonal antibodies based on the molecular cloning and expression of immunoglobulin variable region cDNAs generated from single rabbit or murine lymphocytes that were selected for the production of specific antibodies. Single cells secreting antibodies for a specific peptide either from gp116 of the human cytomegalovirus or from gp120 of HIV-1 or for sheep red blood cells were selected using antigen-specific hemolytic plaque assays. Sheep red blood cells were coated with specific peptides in a procedure applicable to any antigen that can be biotinylated. Heavy- and light-chain variable region cDNAs were rescued from single cells by reverse transcription-PCR and expressed in the context of human immunoglobulin constant regions. These chimeric murine and rabbit monoclonal antibodies replicated the target specificities of the original antibody-forming cells. The selected lymphocyte antibody method exploits the in vivo mechanisms that generate high-affinity antibodies. This method can use lymphocytes from peripheral blood, can exploit a variety of procedures that identify individual lymphocytes producing a particular antibody, and is applicable to the generation of monoclonal antibodies from many species, including humans.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8755564      PMCID: PMC38836          DOI: 10.1073/pnas.93.15.7843

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  Plaque formation in agar by single antibody-producing cells.

Authors:  N K JERNE; A A NORDIN
Journal:  Science       Date:  1963-04-26       Impact factor: 47.728

2.  Antibody production by single cells.

Authors:  G J NOSSAL; J LEDERBERG
Journal:  Nature       Date:  1958-05-17       Impact factor: 49.962

3.  Single, antigen-specific B cells used to generate Fab fragments using CD40-mediated amplification or direct PCR cloning.

Authors:  A C Lagerkvist; C Furebring; C A Borrebaeck
Journal:  Biotechniques       Date:  1995-05       Impact factor: 1.993

4.  Transition-state stabilization as a measure of the efficiency of antibody catalysis.

Authors:  J D Stewart; S J Benkovic
Journal:  Nature       Date:  1995-06-01       Impact factor: 49.962

5.  Neutral adaptation of the genetic code to double-strand coding.

Authors:  J Konecny; M Eckert; M Schöniger; G L Hofacker
Journal:  J Mol Evol       Date:  1993-05       Impact factor: 2.395

6.  Antigen-specific human antibodies from mice comprising four distinct genetic modifications.

Authors:  N Lonberg; L D Taylor; F A Harding; M Trounstine; K M Higgins; S R Schramm; C C Kuo; R Mashayekh; K Wymore; J G McCabe
Journal:  Nature       Date:  1994-04-28       Impact factor: 49.962

7.  Neonatal VH, D, and JH gene usage in rabbit B lineage cells.

Authors:  M L Friedman; C Tunyaplin; S K Zhai; K L Knight
Journal:  J Immunol       Date:  1994-01-15       Impact factor: 5.422

8.  Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies.

Authors:  M Ohlin; V A Sundqvist; M Mach; B Wahren; C A Borrebaeck
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

9.  Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs.

Authors:  L L Green; M C Hardy; C E Maynard-Currie; H Tsuda; D M Louie; M J Mendez; H Abderrahim; M Noguchi; D H Smith; Y Zeng; N E David; H Sasai; D Garza; D G Brenner; J F Hales; R P McGuinness; D J Capon; S Klapholz; A Jakobovits
Journal:  Nat Genet       Date:  1994-05       Impact factor: 38.330

10.  Isolation of high affinity human antibodies directly from large synthetic repertoires.

Authors:  A D Griffiths; S C Williams; O Hartley; I M Tomlinson; P Waterhouse; W L Crosby; R E Kontermann; P T Jones; N M Low; T J Allison
Journal:  EMBO J       Date:  1994-07-15       Impact factor: 11.598

View more
  43 in total

1.  Amplification of IgG VH and VL (Fab) from single human plasma cells and B cells.

Authors:  J A Coronella; P Telleman; T D Truong; F Ylera; R P Junghans
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

Review 2.  New targets for intervention in the treatment of postmenopausal osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Nat Rev Rheumatol       Date:  2011-09-20       Impact factor: 20.543

3.  Osteocyte control of bone formation via sclerostin, a novel BMP antagonist.

Authors:  David G Winkler; May Kung Sutherland; James C Geoghegan; Changpu Yu; Trenton Hayes; John E Skonier; Diana Shpektor; Mechtild Jonas; Brian R Kovacevich; Karen Staehling-Hampton; Mark Appleby; Mary E Brunkow; John A Latham
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

Review 4.  Role of sclerostin in bone and cartilage and its potential as a therapeutic target in bone diseases.

Authors:  E Michael Lewiecki
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-04       Impact factor: 5.346

Review 5.  Sclerostin and skeletal health.

Authors:  Maryam Sharifi; Lisa Ereifej; E Michael Lewiecki
Journal:  Rev Endocr Metab Disord       Date:  2015-06       Impact factor: 6.514

6.  Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation.

Authors:  Vaclav Veverka; Alistair J Henry; Patrick M Slocombe; Andrew Ventom; Barbara Mulloy; Frederick W Muskett; Mariusz Muzylak; Kevin Greenslade; Adrian Moore; Li Zhang; Jianhua Gong; Xueming Qian; Chris Paszty; Richard J Taylor; Martyn K Robinson; Mark D Carr
Journal:  J Biol Chem       Date:  2009-02-10       Impact factor: 5.157

Review 7.  Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design.

Authors:  James E Crowe
Journal:  Cell Host Microbe       Date:  2017-08-09       Impact factor: 21.023

8.  The rapid generation of recombinant functional monoclonal antibodies from individual, antigen-specific bone marrow-derived plasma cells isolated using a novel fluorescence-based method.

Authors:  Alison M Clargo; Ashley R Hudson; Welcome Ndlovu; Rebecca J Wootton; Louise A Cremin; Victoria L O'Dowd; Carla R Nowosad; Dale O Starkie; Sophie P Shaw; Joanne E Compson; Dominic P White; Brendon MacKenzie; James R Snowden; Laura E Newnham; Michael Wright; Paul E Stephens; Meryn R Griffiths; Alastair D G Lawson; Daniel J Lightwood
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

9.  Engineered cell surface expression of membrane immunoglobulin as a means to identify monoclonal antibody-secreting hybridomas.

Authors:  Paul W Price; Elizabeth C McKinney; Youliang Wang; Loren E Sasser; Muthugapatti K Kandasamy; Linda Matsuuchi; Christine Milcarek; Roger B Deal; Deborah G Culver; Richard B Meagher
Journal:  J Immunol Methods       Date:  2009-01-31       Impact factor: 2.303

10.  Antibody discovery via multiplexed single cell characterization.

Authors:  William D Harriman; Ellen J Collarini; Gizette V Sperinde; Magnus Strandh; Marjan M Fatholahi; April Dutta; Yunji Lee; Shelley E Mettler; Bruce A Keyt; Stote L Ellsworth; Lawrence M Kauvar
Journal:  J Immunol Methods       Date:  2008-12-16       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.